WELCOME TO THE
DELVE BLOG
Delve Health Provides the Technology Platform to Design Clinical Trials to Fit a Patient’s Lifestyle
—Not the Other Way Around
A significant number of companies announced delays and cancellations to planned and on-going clinical trials because of COVID-19 lockdowns and social distancing measures. There was a peak of 1,265 trials paused or indefinitely delayed in June 2020—impacting nearly 1,000 companies. Disruptions included delayed initiation or complete withdrawal of planned trials, as well as suspended enrollment or cancellation of on-going trials. The number of disrupted trials has been falling slowly since June 2020, with most current disruptions due to other factors, such as slow enrollment.
REAL-TIME DATA COLLECTION FOR PRIME-TIME OUTCOME ASSESSMENTS
Delve Health
September 30, 2021
With our fully configurable ePRO/eCOA solution, we help assure your team gets the highest quality patient-reported outcomes for your study. The movement from
Are Decentralized Clinical Trials Effective?
Delve Health
July 15, 2021
The COVID-19 pandemic has been an expensive experience, costing months of delay to over 70% of all clinical trials. In the world of clinical research,
What is Decentralized Clinical Trials
Delve Health
May 27, 2021
Clinical Trials come in multiple flavors, including virtual, hybrid, and fully site-based trials. The impact of COVID-19 on the industry of clinical research and drug
Consideration for Device Selection in Clinical Trials
Delve Health
May 18, 2021
W E LCO M E TO T H E D E LV E B LO G . FPO Considering a wearable for an upcoming study?
Apple Watch in Clinical Trials
Delve Health
April 8, 2021
Considering a wearable for your upcoming clinical trial? The Apple Watch is an FDA approved Class II device with a slick, beautiful and powerful utility to help
